Expression and contribution of endogenous IL-13 in an experimental model of sepsis

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2738-2744

  Matsukawa, Akihiro ^a   Hogaboam, Cory M ^a   Lukacs, Nickolas W ^a   Lincoln, Pamela M ^a   Evanoff, Holly L ^a   Strieter, Robert M ^a   Kunkel, Steven L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 13; MESSENGER RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS;

EID: 0034162550     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2738     Document Type: Article

References (37)

1. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644.
2. Astiz, M. E., and E. C. Rackow. 1998. Septic shock. Lancet 351:1501.
3. Hack, C. E., L. A. Aarden, and L. G. Thijs. 1997. Role of cytokines in sepsis. Adv. Immunol. 66:101.
4. Bone, R. C. 1996. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome. Ann. Intern. Med. 125:680.
5. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733.
6. Zurawski, G., J. E. de Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
7. de Vries, J. E. 1996. Molecular and biological characteristics of interleukin-13. Chem. Immunol. 63:204.
8. Colotta, F., S. Saccani, J. G. Giri, S. K. Dower, J. E. Sims, M. Introna, and A. Mantovani. 1996. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156:2534.
9. Colotta, F., F. Re, M. Muzio, N. Polentarutti, A. Minty, D. Caput, P. Ferrara, and A. Mantovani. 1994. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J. Biol. Chem. 269: 12403.
10. Muchamuel, T., S. Menon, P. Pisacane, M. C. Howard, and D. A. Cockayne. 1997. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-α, IFN-γ, and IL-12 production. J. Immunol. 158:2898.
11. Nicoletti, F., G. Mancuso, V. Cusumano, R. Di Marco, P. Zaccone, K. Bendtzen, and G. Teti. 1997. Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur. J. Immunol. 27:1580.
12. Baumhofer, J. M., B. G. Beinhauer, J. E. Wang, H. Brandmeier, K. Geissler, U. Losert, R. Philip, G. Aversa, and M. A. Rogy. 1998. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur. J. Immunol. 28:610.
13. van der Poll, T., R. de Waal Malefyt, S. M. Coyle, and S. F. Lowry. 1997. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J. Infect. Dis. 175:118.
14. Fink, M. P., and S. O. Heard. 1990. Laboratory models of sepsis and septic shock. J. Surg. Res. 49:186.
15. Ruth, J. H., N. W. Lukacs, K. S. Warmington, T. J. Polak, M. Burdick, S. L. Kunkel, R. M. Strieter, and S. W. Chensue. 1998. Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation. J. Immunol. 161:4276.
16. Chomarat, P., and J. Banchereau. 1997. An update on interleukin-4 and its receptor. Eur. Cytokine Network 8:333.
17. Chomarat, P., and J. Banchereau. 1998. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int. Rev. Immunol. 17:1.
18. Klebanoff, S. J., and R. A. Clark. 1978. The Neutrophils: Functional and Clinical Disorders. North-Holland, New York.
19. Kellum, J. A., and J. M. Decker. 1996. The immune system: relation to sepsis and multiple organ failure. AACN Clin. Issues 7:339.
20. Lentsch, A. B., B. J. Czermak, J. A. Jordan, and P. A. Ward. 1999. Regulation of acute lung inflammatory injury by endogenous IL-13. J. Immunol. 162:1071.
21. Watson, M. L., A. M. White, E. M. Campbell, A. W. Smith, J. Uddin, T. Yoshimura, and J. Westwick. 1999. Anti-inflammatory actions of interleukin-13: suppression of tumor necrosis factor-α and antigen-induced leukocyte accumulation in the guinea pig lung. Am. J. Respir. Cell Mol. Biol. 20:1007.
22. Luster, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
23. Bacon, K. B., and J. J. Oppenheim. 1998. Chemokines in disease models and pathogenesis. Cytokine Growth Factor Rev. 9:167.
24. Rollins, B. J. 1997. Chemokines. Blood 90:909.
25. Tracey, K. J. 1994. Tumor necrosis factor-α. In The Cytokine Handbook. A. Thompson, ed. Academic, London, pp. 289-304.
26. van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155:5397.
27. Hogaboam, C. M., M. L. Steinhauser, H. Schock, N. W. Lukacs, R. M. Strieter, T. J. Standiford, and S. L. Kunkel. 1998. Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: role of interleukin-10 and monocytc chemoattractant protein 1. Infect. Immun. 66:650.
28. de Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151:6370.
29. Minty, A., P. Chalon, J. M. Derocq, X. Dumont, J. C. Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, et al. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248.
30. McKenzie, A. N., J. A. Culpepper, R. de Waal Malefyt, F. Briere, J. Punnonen, G. Aversa, A. Sato, W. Dang, B. G. Cocks, S. Menon, et al. 1993. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA 90:3735.
31. Burd, P. R., W. C. Thompson, E. E. Max, and F. C. Mills. 1995. Activated mast cells produce interleukin 13. J. Exp. Med. 181:1373.
32. Ochensberger, B., G. C. Daepp, S. Rihs, and C. A. Dahinden. 1996. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood 88:3028.
33. Hoshino, T., R. T. Winkler-Pickett, A. T. Mason, J. R. Ortaldo, and H. A. Young. 1999. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-γ. J. Immunol. 162: 51.
34. Zurita-Salinas, C. S., A. Palacios-Boix, A. Yanez, F. Gonzalez, and J. Alcocer-Varela. 1996. Contamination with Mycoplasma spp. induces interleukin-13 expression by human skin fibroblasts in culture. FEMS Immunol. Med. Microbiol. 15:123.
35. de Saint-Vis, B., I. Fugier-Vivier, C. Massacrier, C. Gaillard, B. Vanbervliet, S. Ait-Yahia, J. Banchereau, Y. J. Liu, S. Lebecque, and C. Caux. 1998. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. I. Immunol. 160:1666.
36. Takamatsu, Y., M. Hasegawa, S. Sato, and K. Takehara. 1998. IL-13 production by peripheral blood mononuclear cells from patients with atopic dermatitis. Dermatology 196:377.
37. Hancock, A., L. Armstrong, R. Gama, and A. Millar. 1998. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am. J. Respir. Cell Mol. Biol. 18:60.